Staying ahead of product shortages and disruptions is an ongoing challenge for hospitals, surgery centers, specialty practices, and veterinary facilities alike. Today, instability around the Strait of Hormuz is adding new pressure to the global pharmaceutical supply chain, with ripple effects already reaching healthcare procurement teams.
While these events may feel geographically distant, they directly impact the availability and pricing of essential medical supplies. For many facilities, this is showing up as drug shortages, medications on backorder, and tightening access to critical white goods and consumables.
Why Global Conflict Impacts the Pharmaceutical Supply Chain
The Strait of Hormuz is one of the most important shipping routes in the world, carrying a large share of global oil and petrochemical materials. When conflict disrupts channels like this one, it affects far more than energy markets.
Many products used in healthcare depend on:
-
Petrochemical-based raw materials (such as plastics and synthetic rubber)
-
Global manufacturing networks
-
International freight and shipping routes
These inputs are foundational to the pharmaceutical distribution services and medical supply chains that hospitals rely on every day.
When disruption occurs, the result is:
-
Increased raw material costs affecting pharmaceutical and medical supply manufacturing
-
Delays in global shipping routes
-
Manufacturing slowdowns for essential medical products
-
Reduced availability of high-volume consumables
This creates a cascading effect that ultimately impacts hospital pharmacy procurement and medical supply ordering decisions.
How This Is Impacting Healthcare Right Now
We are currently seeing early-stage pressure across high-volume consumables and “white goods” that hospitals depend on daily. These are often the first categories to feel strain during medical supply and pharmaceutical shortages or global supply chain disruptions.
Trending Product Categories and Supply Pressure
Based on current sourcing trends, increased demand, and early market fluctuations, the following categories are being closely monitored:
-
Exam gloves (nitrile and synthetic)
-
Surgical gloves
-
IV catheters
-
IV administration sets
-
Syringes
-
Neuro sponges/Neuro patties, and other surgical consumables
These products are commonly affected during periods of drug backorders and hard-to-source pharmaceuticals because they rely heavily on raw materials that may be affected by significant price increases or availability issues.
As a result, healthcare facilities may begin to experience:
-
Longer lead times on routine orders
-
Increased incidence of medications and supplies on backorder
-
Price fluctuations across commonly used items
-
Reduced availability from primary distributors
Tips to Manage Hospital Supply Chain Shortages
When supply chains tighten, early awareness becomes one of the most important tools for hospital procurement teams.
Here are key signals to monitor:
1. Lead Time Changes
Extended delivery timelines are often one of the earliest indicators of upstream disruption in the pharmaceutical supply chain.
2. Pricing Volatility
Frequent price changes can indicate limiting supply even before formal shortages are announced.
3. Allocation and Purchase Limits
Manufacturers may begin restricting quantities, particularly on high-demand consumables and IV products.
4. Increased Substitutions
A rise in product substitutions often signals strain in standard sourcing channels.
5. Industry Shortage Tracking
Resources such as the American Society of Health-System Pharmacists' shortage list and the U.S. Food and Drug Administration Drug Shortages Database remain critical for tracking national-level drug and supply shortages.
What May Happen Next
While widespread shortages are not confirmed yet, the market is clearly trending into constraint.
If current global disruptions continue, hospitals may expect to see:
-
Increased allocation among the aforementioned medical products
-
Greater reliance on secondary pharmaceutical distributors and alternative drug sourcing channels
-
Continued pricing increases across consumables and injectable products
-
Longer and less predictable manufacturing and distribution cycles
Smaller and independent facilities are often the first to feel the impact due to limited purchasing leverage and lower inventory buffers.
Veterinary Industry Impact
While much of the focus is on human healthcare, the veterinary industry is exposed to the same global pharmaceutical supply chain pressures and may feel the effects even sooner. The U.S. relies heavily on overseas manufacturing for generic drugs and key inputs, many of which move through regions impacted by disruptions near the Strait of Hormuz. When these routes are constrained, it can quickly affect both human and veterinary drug sourcing.
Early conversations across the industry are pointing to potential pressure on:
-
IV fluids and related delivery systems
-
Blood pressure medications
-
Common antibiotics
-
Injectable and sterile products
While widespread shortages are not currently confirmed, these categories are being closely monitored. Many rely on petrochemical-based materials, global manufacturing, and complex sterile production, making them more vulnerable if disruptions persist.
Veterinary providers may begin to see:
-
Increased medications on backorder
-
Limited availability of key generics
-
Pricing volatility
-
Greater competition with human healthcare systems for available supply
Because veterinary practices are often lower priority during allocation cycles, having access to a secondary sourcing partner and alternative drug sourcing becomes critical. Staying ahead of demand and monitoring high-use categories can help maintain continuity of care as supply chain conditions continue to evolve.
How TCC Pharma Supports During Supply Chain Disruptions
At TCC Pharma, we operate as a secondary pharmaceutical distributor and sourcing partner for healthcare facilities navigating shortages, backorders, and supply chain instability.
When traditional channels are constrained, we help hospitals and veterinary practices with:
-
Access to hard-to-source pharmaceuticals and medical supplies
-
Support for medications on backorder and shortage items
-
Flexible drug sourcing solutions across a broad supplier network
-
Visibility into trending and high-demand healthcare products
-
Responsive support for hospital drug sourcing and procurement teams
-
Consistent communication regarding transparent pricing and shipping expectations
Our focus is simple: help healthcare providers maintain continuity of care when the pharmaceutical supply chain is under pressure.
Staying Ahead of Future Supply Disruptions
Global conflict, logistics constraints, and raw material shortages will continue to impact healthcare procurement cycles. The key is not avoiding disruption entirely, but building flexibility into sourcing strategies.
Working with a trusted pharmaceutical sourcing partner can help hospitals reduce downtime, secure critical supplies faster, and navigate shortages more effectively.
Explore our product catalog at tccpharma.com to view trending products, connect with our procurement team, and request a quote for hard-to-source items.
TCC Pharma – Pharmaceutical procurement simplified.